Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2014

View Archived Issues

Early clinical results presented for lentiviral-based anti-HIV therapeutic vaccine

New association of an Alzheimer's-associated polymorphism with major depressive disorder

Pharmacological profile of bifunctional MABAs presented at ATS meeting

New data on lead tetracycline antibiotic presented by Tetraphase

Teriparatide evidences potential for spinal fusion and fractures

Roche patent divulges novel K(Ca)3.1 channel blockers

Cephalon researchers prepare and test bendamustine prodrugs

Ohio State University reports development of gemcitabine analogues

Preliminary findings reported for anti-CD37 ADC in patients with NHL

MSD plans phase III trial of MK-8228 to prevent CMV infection in HSCT recipients

Trevi plans phase II studies of nalbuphine ER in uremic pruritus

Asterias Biotherapeutics receives grant for trial of stem cell therapy in spinal cord injury

Innate Pharma and Enzo Biochem validate ProteoStat for ADC stability testing

QIAGEN and Lilly collaborate on DNA and RNA diagnostic for cancer

Spanish researchers prepare new prolyl endopeptidase inhibitors

Agios Pharmaceuticals discloses new PKLR and/or PKM activators

Novel PI3Kdelta inhibitor demonstrates clinical efficacy for hematologic malignancies

Adaptimmune and GSK establish cancer immunotherapy collaboration

MediWound expands distribution of NexoBrid to South Korea

Sequenom bioscience business acquired by Agena Bioscience

Award to support trial of Sangamo's ZFP therapeutic for HIV/AIDS

The FDA grants orphan drug status to PF-02545920 for Huntington's disease

Health Canada accepts Ravicti NDS for priority review

EMA accepts Hetlioz MAA for review

ChemoCentryx's CCX-168 receives U.S. orphan drug status for ANCA-associated vasculitis

Invega approved in E.U. for schizophrenia in adolescents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...